Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FSFYM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,176
Award facts
- Contract value 100% obligated
- $10,175.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,175.60 to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 mg/mL autoinjector units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The products will be delivered to the Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical prime vendor contract running through December 2026 that supports military healthcare systems globally.
AIMOVIG (erenumab) is a monoclonal antibody treatment used for migraine prevention, representing AmerisourceBergen's continued role as a critical pharmaceutical distributor for federal medical procurement. As a major healthcare solutions provider headquartered in Pennsylvania, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FSFYM?
SPE2DB25FSFYM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FSFYM worth?
The government has obligated $10,176 on SPE2DB25FSFYM.
Is contract SPE2DB25FSFYM an order under another contract?
Yes. SPE2DB25FSFYM is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSFYM competed?
The extent of competition for SPE2DB25FSFYM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award